Category: Gene Therapy
Gene Therapy market research reports by Market Xcel
-
Clinical Trials Market Assessment, By Phase [Phase I, Phase II, Phase III, and Phase IV], By Service Type [Laboratory Services, Bioanalytical and Analytical Testing Services, Patient Recruitment and Site Identification, Clinical Trial Data Management Services, Protocol Designing, Medical Device Testing Services, Other Services], By Therapeutic Area [Oncology, Cardiology, Neurology, Infectious Diseases, Other Therapeutic Areas], By Application [Small Molecules, Vaccines, Cell and Gene Therapies, Monoclonal Antibodies, Other Applications], By Study Designs Outlook [Interventional, Observational, Expanded Access], By Sponsor Type [Pharmaceutical Companies, Medical Devices Companies, Academic Institutes], By Region, Opportunities and Forecast, 2017-2031F
Clinical Trials Market Assessment, By Phase [Phase I, Phase II, Phase III, and Phase IV], By Service Type [Laboratory Services, Bioanalytical and Analytical Testing Services, Patient Recruitment and Site Identification, Clinical Trial Data Management Services, Protocol Designing, Medical Device Tes ... Read More
-
Biologics Safety Testing Market Assessment, By Product and Services [Consumables, Instruments, Services], By Test Type [Residual Host Contamination Detection Tests, Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Tests, Others], By Application [Vaccines and Therapeutics, Blood and Blood Based Products, Gene Therapy, Tissue and Tissue Based Products, Stem Cell], By End-user [Pharmaceutical and Biotechnology Companies, Clinical Research Organizations and Contract Development and Manufacturing Organizations, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F
Biologics Safety Testing Market Assessment, By Product and Services [Consumables, Instruments, Services], By Test Type [Residual Host Contamination Detection Tests, Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Sterility Tests, Endotoxin Te ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Augmentation, Gene Silencing, Others], By Vector [Viral Vectors, Non-Viral Vectors], By Gene Delivery Method [In vivo, Ex vivo], By Application [Oncological Diseases, Genetic Diseases, Cardiovascular Diseases, Neuromuscular Diseases, Hematological Diseases, Infectious Diseases, Others], By Route of Administration [Intravenous, Others], By End-user [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
Gene Therapy Market Assessment, By Type [Gene Augmentation, Gene Silencing, Others], By Vector [Viral Vectors, Non-Viral Vectors], By Gene Delivery Method [In vivo, Ex vivo], By Application [Oncological Diseases, Genetic Diseases, Cardiovascular Diseases, Neuromuscular Diseases, Hematological Diseas ... Read More
-
Fill-Finish Manufacturing Market Assessment, By Product Type [Consumables, Instruments], By Modality [Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others], By End-user [Contract Manufacturing Companies, Pharmaceutical and Biopharmaceutical Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
Fill-Finish Manufacturing Market Assessment, By Product Type [Consumables, Instruments], By Modality [Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others], By End-user [Contract Manufacturing Companies, Pharmaceutical and Biophar ... Read More
-
Beta Thalassemia Market Assessment, By Type [Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major], By Therapy [Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy, Bone Marrow Transplants], By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies], By Region, Opportunities and Forecast, 2017-2031F
Beta Thalassemia Market Assessment, By Type [Beta Thalassemia Minor, Beta Thalassemia Intermedia, Beta Thalassemia Major], By Therapy [Blood Transfusions, Iron Chelation Therapy, Folic Acid Supplements, Gene Therapy, Bone Marrow Transplants], By Distribution Channel [Hospital Pharmacies, Retail Phar ... Read More
-
Nanobiotechnology Market Assessment, By Type [0-10 Nm, 10-100 Nm], By Therapeutics [Dental Therapies, Cardiac Therapies, Orthopedic Therapies, Others], By Technology [Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others], By Application [Therapeutics, Nano diagnostics, Tissue Engineering, Gene Therapy, Molecular Nanotechnology, Drug Delivery, Food Safety], By End-user [Pharmaceutical Companies, Research Institutes and Laboratories, Academic Institutions, Others], By Region, Opportunities and Forecast, 2017-2031F
Nanobiotechnology Market Assessment, By Type [0-10 Nm, 10-100 Nm], By Therapeutics [Dental Therapies, Cardiac Therapies, Orthopedic Therapies, Others], By Technology [Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others], By Application [Therapeutics, Nano diagnostics, Tissue Engineer ... Read More
-
Regenerative Medicine Market Assessment, By Component [Therapeutics, Tools, Banks, Services], By Product [Gene Therapy, Cell Therapy, Tissue Engineering, Organ Therapy, Small Molecules and Biologics], By Material [Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Others], By Application [Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, Dermatology, Neurology, Others], By End-user [Hospitals, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
Regenerative Medicine Market Assessment, By Component [Therapeutics, Tools, Banks, Services], By Product [Gene Therapy, Cell Therapy, Tissue Engineering, Organ Therapy, Small Molecules and Biologics], By Material [Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Ot ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Silencing, Cell Replacement, Gene Augmentation, Others], By Vector [Non-Viral Vectors, Viral Vectors], By Gene Delivery Method [Ex vivo and In vivo], By Application [Oncological Diseases, Neuromuscular Diseases, Cardiovascular Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
Gene Therapy Market Assessment, By Type [Gene Silencing, Cell Replacement, Gene Augmentation, Others], By Vector [Non-Viral Vectors, Viral Vectors], By Gene Delivery Method [Ex vivo and In vivo], By Application [Oncological Diseases, Neuromuscular Diseases, Cardiovascular Diseases, Infectious Diseas ... Read More
Research Assistance
